Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Neuropsychiatric Update: Neuroimaging Schizophrenia
1
x
$
30.00
VOL 3 No. 8 Full Issue - August 2001
1
x
$
20.00
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
1
x
$
30.00
Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study
1
x
$
30.00
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
1
x
$
30.00
Efficacy of High-Dose Aripiprazole for Treatment-Resistant Schizoaffective Disorder: A Case Report
1
x
$
30.00
Assesment of Risk Factors for Tardive Dyskinesia (OPEN ACCESS)
1
x
$
0.00
Theoretical Potential of Hericium Erinaceus Supplementation as an Add-On to Antipsychotics in Chronic and Treatment-Resistant Schizophrenia
1
x
$
30.00
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
1
x
$
30.00
Intravenous Lidocaine Infusion for the Management of Early Postoperative Pain: A Comprehensive Review of Controlled Trials (OPEN ACCESS)
1
x
$
0.00
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder
1
x
$
30.00
View Cart
Checkout
Home
Store
“Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Paroxetine Use in Medically Ill Patients
$
30.00
Add to cart
Details
Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
$
30.00
Add to cart
Details
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
$
30.00
Add to cart
Details
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Treatment of Panic Disorder: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
$
30.00
Add to cart
Details
Management of Late-Life Depression: Focus on Comorbid Conditions
$
30.00
Add to cart
Details
Gender-Specific Differences in Depression and Treatment Response
$
30.00
Add to cart
Details
New Advances in the Management of Anxiety Disorders
$
30.00
Add to cart
Details
Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety
$
30.00
Add to cart
Details
Strategies for Treatment-Resistant Depression
$
30.00
Add to cart
Details
Long-Term Antidepressant Treatment
$
30.00
Add to cart
Details
Remission as the Critical Outcome of Depression Treatment
$
30.00
Add to cart
Details
New Developments in Depression and Anxiety Disorders
$
30.00
Add to cart
Details
Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Previous
1
…
37
38
39
…
44
Next
Page load link
Go to Top
